{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:42Z","timestamp":1786982382608,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kochi Organization for Medical Reformation and Renewal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We present a rare case of olmesartan-associated gastroduodenitis in a 65-year-old female with predominant upper gastrointestinal symptoms and significant changes in endoscopic findings over a short period. The patient presented with epigastralgia and nausea but no diarrhea. Esophagogastroduodenoscopy (EGD) performed 26\u00a0months earlier showed a duodenal ulcer and partial mucosal atrophy in the lower gastric body. EGD conducted at our hospital revealed diffuse atrophic mucosa throughout the stomach and fragile mucosa from the middle gastric body to the antrum, with white purulent adhesions. Diffuse inflammatory changes were also observed in the duodenal bulb and descending part. Mucosal biopsy showed atrophic changes, inflammatory cell infiltrations, and epithelial detachments in both the stomach and duodenum. Colonoscopy findings were normal. After discontinuing olmesartan, the patient\u2019s symptoms improved immediately. A follow-up EGD conducted 4\u00a0months after discontinuation revealed marked improvement in the stomach and duodenum. At 16\u00a0months post-discontinuation, the patient remained asymptomatic, with minimal inflammation and residual gastric atrophy observed on EGD. This case underscores the importance of considering olmesartan as a potential cause of gastroduodenitis, particularly when symptoms and endoscopic findings improve after discontinuation of the medication.<\/jats:p>","DOI":"10.1007\/s12328-025-02137-8","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T07:51:51Z","timestamp":1746345111000},"page":"563-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Olmesartan-associated gastroduodenitis that was detected on endoscopic follow-up"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4988-4875","authenticated-orcid":false,"given":"Yusuke","family":"Oki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Tatsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushige","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,4]]},"reference":[{"key":"2137_CR1","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12876-021-01926-y","volume":"21","author":"S Kaneko","year":"2021","unstructured":"Kaneko S, Matsuda K, Mizuta Y, et al. Severe spruelike enteropathy and collagenous colitis caused by Olmesartan. BMC Gastroenterol. 2021;21:350. https:\/\/doi.org\/10.1186\/s12876-021-01926-y.","journal-title":"BMC Gastroenterol"},{"key":"2137_CR2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/apt.17855","volume":"59","author":"A Schiepatti","year":"2024","unstructured":"Schiepatti A, Minerba P, Puricelli M, et al. Systematic review: clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers. Aliment Pharmacol Ther. 2024;59:432\u201344.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"2137_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54373","volume":"16","author":"SG Doukas","year":"2024","unstructured":"Doukas SG, Doukas PG, Velpari S. Non-celiac enteropathy and olmesartan: an essential consideration. Cureus. 2024;16(2): e54373. https:\/\/doi.org\/10.7759\/cureus.54373.","journal-title":"Cureus"},{"key":"2137_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","volume":"87","author":"A Rubio-Tapia","year":"2012","unstructured":"Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. Severe sprue-like enteropathy associated with olmesartan. Mayo Clin Proc. 2012;87:732\u20138.","journal-title":"Mayo Clin Proc"},{"key":"2137_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.mayocp.2012.10.005","volume":"87","author":"J Menne","year":"2012","unstructured":"Menne J, Haller H. Olmesartan and intestinal adverse effects in the ROADMAP study. Mayo Clin Proc. 2012;87:1230\u20131.","journal-title":"Mayo Clin Proc"},{"key":"2137_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-226133","volume":"11","author":"L Shenbagaraj","year":"2018","unstructured":"Shenbagaraj L, Swift G. Olmesartan-associated severe gastritis and enteropathy. BMJ Case Rep. 2018;11: e226133. https:\/\/doi.org\/10.1136\/bcr-2018-226133.","journal-title":"BMJ Case Rep"},{"key":"2137_CR7","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/S0140-6736(24)02129-9","volume":"404","author":"A Higashimori","year":"2024","unstructured":"Higashimori A, Maeda N, Kato M, et al. Olmesartan-induced collagenous gastritis. Lancet. 2024;404:1444. https:\/\/doi.org\/10.1016\/S0140-6736(24)02129-9.","journal-title":"Lancet"},{"issue":"6","key":"2137_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125024","volume":"10","author":"S Scialom","year":"2015","unstructured":"Scialom S, Malamut G, Meresse B, et al. Gastrointestinal disorder associated with olmesartan mimics autoimmune enteropathy. PLoS ONE. 2015;10(6): e0125024. https:\/\/doi.org\/10.1371\/journal.pone.0125024.","journal-title":"PLoS ONE"},{"issue":"11\u201312","key":"2137_CR9","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.13413","volume":"42","author":"EV Marietta","year":"2015","unstructured":"Marietta EV, Nadeau AM, Cartee AK, et al. Immunopathogenesis of olmesartan-associated enteropathy. Aliment Pharmacol Ther. 2015;42(11\u201312):1303\u201314.","journal-title":"Aliment Pharmacol Ther"},{"key":"2137_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102609","volume":"118","author":"RLJ van Wanrooij","year":"2021","unstructured":"van Wanrooij RLJ, Bontkes HJ, Neefjes-Borst EA, et al. Immune-mediated enteropathies: from bench to bedside. J Autoimmun. 2021;118: 102609. https:\/\/doi.org\/10.1016\/j.jaut.2021.102609.","journal-title":"J Autoimmun"},{"issue":"5","key":"2137_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/his.14766","volume":"81","author":"T Storozuk","year":"2022","unstructured":"Storozuk T, Brown I, Lagana S, et al. The histological spectrum of ARB-induced gastritis. Histopathology. 2022;81(5):653\u201360.","journal-title":"Histopathology"},{"key":"2137_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1443-1661.2012.01357.x","volume":"25","author":"S Nomura","year":"2013","unstructured":"Nomura S, Terao S, Adachi K, Kato T, Ida K, et al. Endoscopic diagnosis of gastric mucosal activity and inflammation. Dig Endosc. 2013;25:136\u201346. https:\/\/doi.org\/10.1111\/j.1443-1661.2012.01357.x.","journal-title":"Dig Endosc"},{"key":"2137_CR13","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12876-023-02772-w","volume":"23","author":"K Haruma","year":"2023","unstructured":"Haruma K, Kinoshita Y, Yao T, et al. Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis. BMC Gastroenterol. 2023;23:139.","journal-title":"BMC Gastroenterol"},{"key":"2137_CR14","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/den.13500","volume":"32","author":"S Terao","year":"2020","unstructured":"Terao S, Suzuki S, Yaita H, et al. Multicenter study of autoimmune gastritis in Japan: clinical and endoscopic characteristics. Dig Endosc. 2020;32:364\u201372.","journal-title":"Dig Endosc"},{"issue":"10","key":"2137_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.dld.2021.07.002","volume":"53","author":"M Costetti","year":"2021","unstructured":"Costetti M, Schiepatti A, Fraticelli S, et al. Clinical and gastro-duodenal histopathological features of enteropathy due to angiotensin II receptor blockers. Dig Liver Dis. 2021;53(10):1262\u20137.","journal-title":"Dig Liver Dis"},{"key":"2137_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/imr.12191","volume":"260","author":"V Abadie","year":"2014","unstructured":"Abadie V, Jabri B. IL-15: a central regulator of celiac disease immunopathology. Immunol Rev. 2014;260:221\u201334.","journal-title":"Immunol Rev"},{"key":"2137_CR17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4551-24","author":"M Fujisawa","year":"2024","unstructured":"Fujisawa M, Yoshizaki T, Urakami S, et al. A case of olmesartan-associated gastritis observed over time. Intern Med. 2024. https:\/\/doi.org\/10.2169\/internalmedicine.4551-24.","journal-title":"Intern Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-025-02137-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-025-02137-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T13:21:50Z","timestamp":1757164910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-025-02137-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1007\/s12328-025-02137-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,4]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from the patient for the publication of this case report and accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures were performed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the 1975 Declaration of Helsinki, as revised in 2008 (5).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}}]}}